N
NovAccel
Japan · Healthtech · Hardware
Develops compact superconducting accelerators to produce medical radioisotopes.
Product
NovAccel develops RiSA, a compact superconducting electron accelerator designed for medical radioisotope production. The Japanese company aims to build a stable supply of actinium-225 for targeted alpha therapies.
Its work combines accelerator engineering with isotope-production processes, sample supply and quality control. NovAccel collaborates with research institutions and pharmaceutical partners as it prepares the technology and supply chain for commercial production.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Post-seed extension | ~¥290M | INOUE CORPORATION — ParticipantXTech Fund 3 — Participant |